Subscribe Now
Rankings
Magazine
Newsletters
Podcasts
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
Rankings
See All Rankings
Fortune 500
Global 500
40 Under 40
GREAT PLACE TO WORK LISTS
Best MBA Programs
Magazine
Newsletters
Podcasts
More
Video On Demand
Fortune Live Media
Fortune Connect
Fortune Education
Fortune Well
Fortune Crypto
Fortune Recommends
SEARCH
SEARCH
SIGN IN
Subscribe Now
Mylan
Magazine
Insulin’s deadly cost: Ultrahigh prices in the U.S. mean many diabetics can’t afford the medication they need to survive
BY
Geoff Colvin
December 6, 2021
Health
Generic Drug Industry Sees New Giant as Pfizer Merges Off-Patent Unit With Mylan
BY
Timothy Annett
,
Riley Ray Griffin
, and others
July 29, 2019
Health
There’s Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product
BY
Sy Mukherjee
September 7, 2018
Health
The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year
BY
Sy Mukherjee
August 16, 2018
Health
Mylan Is Surging and Teva Is Slumping After the FDA Okayed This New Drug
BY
Reuters
October 4, 2017
Retail
Investors Are Calling on Mylan’s Chairman and Director to Step Down
BY
Reuters
June 29, 2017
Health
EpiPen Maker Mylan Saves Millions in Taxes Thanks to Huge Stakes in Coal Companies
BY
Sy Mukherjee
June 21, 2017
Health
Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan?
BY
Sy Mukherjee
June 19, 2017
Health
Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages
BY
Reuters
June 13, 2017
Health
Mylan’s Shareholders Fight to Dump Its Board After the Epipen Scandal
BY
Reuters
May 31, 2017
Finance
Mylan’s EpiPen Recall Couldn’t Come at a Worse Time
BY
Jen Wieczner
April 3, 2017
Health
Mylan’s Massive Recall of Faulty EpiPens Spreads to the U.S.
BY
Aric Jenkins
April 1, 2017
Health
FDA Rejects Mylan’s Copycat of GSK’s Asthma Drug
BY
Sy Mukherjee
March 30, 2017
Health
Mylan Recalls 81,000 EpiPens Outside U.S. After Reports of Failure
BY
Reuters
March 23, 2017
Health
Mylan’s EpiPen Is Bleeding Market Share to Its Rivals
BY
Sy Mukherjee
March 6, 2017
Load More
Most Popular
Health
‘Yeah, I was wrong’: Anthony Fauci opens up on his regrets in new PBS ‘American Masters’ documentary
March 21, 2023
BY
Mark Kennedy
and
The Associated Press
Finance
‘Already past the point of no return’: JPMorgan says the U.S. is probably headed for a recession as economic ‘engines...
March 21, 2023
BY
Tristan Bove
Finance
An economist who correctly predicted the Great Financial Crisis says the world’s central banks have chosen ‘class war...
March 21, 2023
BY
Tristan Bove